{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:18:58Z","timestamp":1784945938425,"version":"3.55.0"},"reference-count":183,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.pharmthera.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T07:17:25Z","timestamp":1495091845000},"page":"48-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes"],"prefix":"10.1016","volume":"176","author":[{"given":"Isik","family":"Turker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2017.05.001_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0092-8674(00)80728-X","article-title":"MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia","volume":"97","author":"Abbott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0010","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace: European Pacing, Arrythmias, and Cardiac Electrophysiology: Journal of the Worknig Groups on Cardiac Pacing, Arrythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0015","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1046\/j.1460-9592.2001.01420.x","article-title":"Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome","volume":"24","author":"Alings","year":"2001","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1540-8167.2001.00268.x","article-title":"The Brugada syndrome: Ionic basis and arrhythmia mechanisms","volume":"12","author":"Antzelevitch","year":"2001","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0025","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.hrthm.2005.05.013","article-title":"In vivo human demonstration of phase 2 reentry","volume":"2","author":"Antzelevitch","year":"2005","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.hrthm.2005.01.005","article-title":"Brugada syndrome: Report of the second consensus conference","volume":"2","author":"Antzelevitch","year":"2005","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.0000152479.54298.51","article-title":"Brugada syndrome: Report of the second consensus conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association","volume":"111","author":"Antzelevitch","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb9000","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.joa.2016.07.002","article-title":"J-wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge","volume":"32","author":"Antzelevitch","year":"2016","journal-title":"Journal of Arrhythmia"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0040","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1540-8167.2005.40564.x","article-title":"Propranolol intoxication revealing a Brugada syndrome","volume":"16","author":"Aouate","year":"2005","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/CIRCULATIONAHA.106.658021","article-title":"Prevalence of long-QT syndrome gene variants in sudden infant death syndrome","volume":"115","author":"Arnestad","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0050","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/clc.4950250809","article-title":"Tricyclic antidepressants and the Brugada syndrome: An example of Brugada waves appearing after the administration of desipramine","volume":"25","author":"Babaliaros","year":"2002","journal-title":"Clinical Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/europace\/eus175","article-title":"Fever outperforms flecainide test in the unmasking of type 1 Brugada syndrome electrocardiogram","volume":"15","author":"Barra","year":"2013","journal-title":"Europace: European Pacing, Arrythmias, and Cardiac Electrophysiology: Journal of the Worknig Groups on Cardiac Pacing, Arrythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0060","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.annemergmed.2007.01.027","article-title":"Brugada electrocardiographic pattern induced by cocaine toxicity","volume":"49","author":"Bebarta","year":"2007","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.108.786954","article-title":"Letter by Behr and Camm regarding article, \u201cinduced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias\u201d","volume":"118","author":"Behr","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0070","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCEP.115.003109","article-title":"Management of Brugada syndrome: Thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs","volume":"8","author":"Belhassen","year":"2015","journal-title":"Circulation. Arrhythmia and Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0075","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1021\/pr200339n","article-title":"The cardiac sodium channel is post-translationally modified by arginine methylation","volume":"10","author":"Beltran-Alvarez","year":"2011","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0080","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2008.07.052","article-title":"Gender differences in clinical manifestations of Brugada syndrome","volume":"52","author":"Benito","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0085","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/ng.2712","article-title":"Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death","volume":"45","author":"Bezzina","year":"2013","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.105.580811","article-title":"Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction","volume":"113","author":"Bezzina","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0095","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/0310057X0503300219","article-title":"Brugada syndrome following tricyclic antidepressant overdose","volume":"33","author":"Bigwood","year":"2005","journal-title":"Anaesthesia and Intensive Care"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0002-9149(96)00727-8","article-title":"Abnormal ventricular repolarization mimicking myocardial infarction after heterocyclic antidepressant overdose","volume":"79","author":"Bolognesi","year":"1997","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/CIRCRESAHA.108.188698","article-title":"Developmental basis for electrophysiological heterogeneity in the ventricular and outflow tract myocardium as a substrate for life-threatening ventricular arrhythmias","volume":"104","author":"Boukens","year":"2009","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0110","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","article-title":"Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report","volume":"20","author":"Brugada","year":"1992","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0115","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/01.CIR.101.5.510","article-title":"Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts","volume":"101","author":"Brugada","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00005344-199810000-00004","article-title":"Mechanism of block of cardiac transient outward K+ current (I(to)) by antidepressant drugs","volume":"32","author":"Casis","year":"1998","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0125","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/eurheartj\/ehp252","article-title":"Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities","volume":"30","author":"Catalano","year":"2009","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/32675","article-title":"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation","volume":"392","author":"Chen","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1540-8167.2001.00108.x","article-title":"Vasospastic angina accompanied by Brugada-type electrocardiographic abnormalities","volume":"12","author":"Chinushi","year":"2001","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jelectrocard.2005.10.002","article-title":"Shortening of the ventricular fibrillatory intervals after administration of verapamil in a patient with Brugada syndrome and vasospastic angina","volume":"39","author":"Chinushi","year":"2006","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0145","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1111\/j.1540-8159.2010.02924.x","article-title":"Isolated tramadol overdose associated with Brugada ECG pattern","volume":"35","author":"Cole","year":"2012","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0150","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/jama.2014.13752","article-title":"Follow-up from childhood to adulthood of individuals with family history of Brugada syndrome and normal electrocardiograms","volume":"312","author":"Conte","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0155","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/CIRCULATIONAHA.105.532614","article-title":"Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: A combined electrophysiological, genetic, histopathologic, and computational study","volume":"112","author":"Coronel","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0160","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejphar.2005.12.079","article-title":"Effects of cyamemazine on hERG, INa, ICa, Ito, Isus and IK1 channel currents, and on the QTc interval in guinea pigs","volume":"532","author":"Crumb","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0165","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2174\/157340309788970397","article-title":"Iatrogenic QT abnormalities and fatal arrhythmias: Mechanisms and clinical significance","volume":"5","author":"Cubeddu","year":"2009","journal-title":"Current Cardiology Reviews"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1573403X12666160301120217","article-title":"Drug-induced inhibition and trafficking disruption of ion channels: Pathogenesis of QT abnormalities and drug-induced fatal arrhythmias","volume":"12","author":"Cubeddu","year":"2016","journal-title":"Current Cardiology Reviews"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0175","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","article-title":"A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome","volume":"80","author":"Curran","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0180","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/CIRCULATIONAHA.105.548487","article-title":"Unmasking of brugada syndrome by lithium","volume":"112","author":"Darbar","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0185","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1476-5381.1992.tb14357.x","article-title":"Effects of imipramine on the transient outward current in rabbit atrial single cells","volume":"106","author":"Delpon","year":"1992","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0190","first-page":"263","article-title":"Ventricular tachycardia with 2 variable opposing foci","volume":"59","author":"Dessertenne","year":"1966","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0195","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/01.CIR.0000032002.22105.7A","article-title":"Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males","volume":"106","author":"Di Diego","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0200","first-page":"H548","article-title":"I(to) and action potential notch are smaller in left vs. right canine ventricular epicardium","volume":"271","author":"Di Diego","year":"1996","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-200038010-00003","article-title":"Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition","volume":"38","author":"Dresser","year":"2000","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0210","first-page":"185","article-title":"Cardiac K+ channels and drug-acquired long QT syndrome","volume":"55","author":"Drici","year":"2000","journal-title":"Th\u00e9rapie"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0215","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00004714-199812000-00011","article-title":"Prolongation of QT interval in isolated feline hearts by antipsychotic drugs","volume":"18","author":"Drici","year":"1998","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0220","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0022-3565(24)37646-3","article-title":"Blockade of HERG and Kv1.5 by ketoconazole","volume":"286","author":"Dumaine","year":"1998","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0225","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.RES.85.9.803","article-title":"Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent","volume":"85","author":"Dumaine","year":"1999","journal-title":"Circulation Research"},{"issue":"693","key":"10.1016\/j.pharmthera.2017.05.001_bb0230","first-page":"e691","article-title":"Oxcarbazepine-induced resistant ventricular fibrillation in an apparently healthy young man","volume":"29","author":"El-Menyar","year":"2011","journal-title":"The American Journal of Emergency Medicine"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0235","series-title":"Genetics of Brugada syndrome","author":"Fern\u00e1ndez-Falgueras","year":"2016"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0240","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.hrthm.2004.03.061","article-title":"Role of sodium and calcium channel block in unmasking the Brugada syndrome","volume":"1","author":"Fish","year":"2004","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0245","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1540-8167.2007.01025.x","article-title":"Cellular mechanism and arrhythmogenic potential of T-wave alternans in the Brugada syndrome","volume":"19","author":"Fish","year":"2008","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0250","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1540-8167.1999.tb00662.x","article-title":"ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: Insight into the mechanism of Brugada syndrome","volume":"10","author":"Fujiki","year":"1999","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph1015s57","article-title":"Whole-cell configuration of the patch-clamp technique in the hERG channel assay to predict the ability of a compound to prolong QT interval","author":"Goineau","year":"2012","journal-title":"Current Protocols in Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0260","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJM200205163462020","article-title":"Overdose of cyclic antidepressants and the Brugada syndrome","volume":"346","author":"Goldgran-Toledano","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0008-6363(99)00306-5","article-title":"Voltage-gated calcium-channels and antiarrhythmic drug action","volume":"45","author":"Grace","year":"2000","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0270","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1124\/mol.110.069419","article-title":"Involvement of caveolin in probucol-induced reduction in hERG plasma-membrane expression","volume":"79","author":"Guo","year":"2011","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0275","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1124\/jpet.107.120931","article-title":"Identification of IKr and its trafficking disruption induced by probucol in cultured neonatal rat cardiomyocytes","volume":"321","author":"Guo","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0280","first-page":"143","article-title":"Ethanol inhibition of Ca2+ and Na+ currents in the guinea-pig heart","volume":"292","author":"Habuchi","year":"1995","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0285","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1292\/jvms.60.479","article-title":"Tonic block of the sodium and calcium currents by ketamine in isolated guinea pig ventricular myocytes","volume":"60","author":"Hara","year":"1998","journal-title":"The Journal of Veterinary Medical Science"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0290","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1042\/CS20030351","article-title":"Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG","volume":"107","author":"Hayashi","year":"2004","journal-title":"Clinical Science"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0295","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.yjmcc.2004.10.015","article-title":"Cryptic 5\u2032 splice site activation in SCN5A associated with Brugada syndrome","volume":"38","author":"Hong","year":"2005","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"Suppl A","key":"10.1016\/j.pharmthera.2017.05.001_bb0300","doi-asserted-by":"crossref","first-page":"A50","DOI":"10.1253\/circj.71.A50","article-title":"Disorders of cardiac repolarization: Long QT and short QT syndromes","volume":"71","author":"Horie","year":"2007","journal-title":"Circulation Journal"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0305","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/eurheartj\/ehv695","article-title":"The genetics underlying acquired long QT syndrome: Impact for genetic screening","volume":"37","author":"Itoh","year":"2016","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0310","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/CIRCEP.109.862649","article-title":"Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome","volume":"2","author":"Itoh","year":"2009","journal-title":"Circulation. Arrhythmia and Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0315","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1253\/jcj.63.493","article-title":"A case of vasospastic angina presenting Brugada-type ECG abnormalities","volume":"63","author":"Itoh","year":"1999","journal-title":"Japanese Circulation Journal"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0320","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-8703(57)90079-0","article-title":"Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death","volume":"54","author":"Jervell","year":"1957","journal-title":"American Heart Journal"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0325","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/sj.bjp.0703222","article-title":"Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline","volume":"129","author":"Jo","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0330","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.joa.2016.07.012","article-title":"Genetics of Brugada syndrome","volume":"32","author":"Juang","year":"2016","journal-title":"Journal of Arrhythmia"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0335","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.107.746495","article-title":"Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias","volume":"117","author":"Junttila","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0340","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCGENETICS.111.960930","article-title":"A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes","volume":"5","author":"Kaab","year":"2012","journal-title":"Circulation. Cardiovascular Genetics"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0345","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.hrthm.2009.09.069","article-title":"An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing","volume":"7","author":"Kapplinger","year":"2010","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0350","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.CIR.95.9.2277","article-title":"Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease","volume":"95","author":"Kasanuki","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0355","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0002-9149(00)01351-5","article-title":"Electrocardiographic patterns of the Brugada syndrome in right ventricular infarction\/ischemia","volume":"86","author":"Kataoka","year":"2000","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0360","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1124\/jpet.105.093393","article-title":"Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs","volume":"316","author":"Katchman","year":"2006","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0365","first-page":"1335","article-title":"Consistent linkage of the long-QT syndrome to the Harvey ras-1 locus on chromosome 11","volume":"49","author":"Keating","year":"1991","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0370","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cardiores.2005.03.024","article-title":"Brugada syndrome and fever: Genetic and molecular characterization of patients carrying SCN5A mutations","volume":"67","author":"Keller","year":"2005","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0375","first-page":"H1601","article-title":"Calmodulin antagonists depress calcium and potassium currents in ventricular and vascular myocytes","volume":"253","author":"Klockner","year":"1987","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0380","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.hrthm.2016.03.016","article-title":"Drug-induced Brugada syndrome: Clinical characteristics and risk factors","volume":"13","author":"Konigstein","year":"2016","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0385","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/01.RES.69.2.277","article-title":"Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium","volume":"69","author":"Krishnan","year":"1991","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0390","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1540-8167.1998.tb00088.x","article-title":"ST segment elevation induced by class IC antiarrhythmic agents: Underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia","volume":"9","author":"Krishnan","year":"1998","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0395","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.vascn.2016.08.007","article-title":"Significance of integrated in silico transmural ventricular wedge preparation models of human non-failing and failing hearts for safety evaluation of drug candidates","volume":"83","author":"Kubo","year":"2017","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0400","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1046\/j.1460-9592.2002.01660.x","article-title":"Brugada syndrome unmasked by febrile illness","volume":"25","author":"Kum","year":"2002","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0405","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/01.RES.62.1.116","article-title":"Transient outward current prominent in canine ventricular epicardium but not endocardium","volume":"62","author":"Litovsky","year":"1988","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0410","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.RES.67.3.615","article-title":"Differences in the electrophysiological response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium","volume":"67","author":"Litovsky","year":"1990","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0415","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4065\/75.8.845","article-title":"Brugada-type electrocardiographic pattern induced by cocaine","volume":"75","author":"Littmann","year":"2000","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0420","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1540-8159.2005.00154.x","article-title":"Diphenhydramine overdose and Brugada sign","volume":"28","author":"Lopez-Barbeito","year":"2005","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0425","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/01.CIR.0000027139.42087.B6","article-title":"Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation","volume":"106","author":"Makita","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0430","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1540-8159.2000.tb06774.x","article-title":"Unmasking effect of propafenone on the concealed form of the Brugada phenomenon","volume":"23","author":"Matana","year":"2000","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0435","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1046\/j.1460-9592.2003.t01-1-00227.x","article-title":"Disappearance of the Brugada-type electrocardiogram after surgical castration: A role for testosterone and an explanation for the male preponderance","volume":"26","author":"Matsuo","year":"2003","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0440","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1540-8167.1998.tb01843.x","article-title":"Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome","volume":"9","author":"Matsuo","year":"1998","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0445","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0450","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/tpj.2009.1","article-title":"Influence of the G2677T\/C3435T haplotype of MDR1 on P-glycoprotein trafficking and ibutilide-induced block of HERG","volume":"9","author":"McBride","year":"2009","journal-title":"The Pharmacogenomics Journal"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0455","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cardiores.2005.03.005","article-title":"Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more?","volume":"67","author":"Meregalli","year":"2005","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0460","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1540-8167.2011.02196.x","article-title":"Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants","volume":"23","author":"Minoura","year":"2012","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0465","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cvr\/cvr044","article-title":"Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk","volume":"91","author":"Mirams","year":"2011","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0470","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1073\/pnas.210244497","article-title":"A structural basis for drug-induced long QT syndrome","volume":"97","author":"Mitcheson","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0475","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/047002142X.ch11","article-title":"Structural determinants for high-affinity block of hERG potassium channels","volume":"266","author":"Mitcheson","year":"2005","journal-title":"Novartis Foundation Symposium"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0480","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0735-1097(95)00613-3","article-title":"Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome","volume":"27","author":"Miyazaki","year":"1996","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0485","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1540-8167.2004.03601.x","article-title":"Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome","volume":"15","author":"Mizumaki","year":"2004","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0490","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1540-8159.2008.01085.x","article-title":"Concomitant-acquired long QT and Brugada syndromes associated with indapamide-induced hypokalemia and hyponatremia","volume":"31","author":"Mok","year":"2008","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0495","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1540-8167.2002.00816.x","article-title":"Spontaneous T wave alternans and premature ventricular contractions during febrile illness in a patient with Brugada syndrome","volume":"13","author":"Morita","year":"2002","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0500","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/01.CIR.84.3.1136","article-title":"The long QT syndrome. Prospective longitudinal study of 328 families","volume":"84","author":"Moss","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0505","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium","volume":"123","author":"Nademanee","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0510","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1161\/01.CIR.96.8.2595","article-title":"Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men","volume":"96","author":"Nademanee","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0515","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/0140-6736(91)91786-T","article-title":"Pathogenesis of sudden unexplained nocturnal death (lai tai) and endemic distal renal tubular acidosis","volume":"338","author":"Nimmannit","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0520","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1046\/j.1540-8167.2004.04041.x","article-title":"Canine model of Brugada syndrome using regional epicardial cooling of the right ventricular outflow tract","volume":"15","author":"Nishida","year":"2004","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0525","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jacc.2009.06.005","article-title":"D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome","volume":"54","author":"Nishio","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0530","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1540-8167.2003.02389.x","article-title":"Effects of glucose-induced insulin secretion on ST segment elevation in the Brugada syndrome","volume":"14","author":"Nishizaki","year":"2003","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0535","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0735-1097(02)02494-4","article-title":"ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and\/or ergonovine maleate in patients with Brugada syndrome","volume":"40","author":"Noda","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0540","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1540-8167.2003.02384.x","article-title":"Prominent J wave and ST segment elevation: Serial electrocardiographic changes in accidental hypothermia","volume":"14","author":"Noda","year":"2003","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0545","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1460-9592.2003.00044.x","article-title":"Enhancement of J-ST-segment elevation by the glucose and insulin test in Brugada syndrome","volume":"26","author":"Nogami","year":"2003","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0550","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1476-5381.1989.tb12031.x","article-title":"Block of sodium channels by psychotropic drugs in single guinea-pig cardiac myocytes","volume":"97","author":"Ogata","year":"1989","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0555","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.hrthm.2007.02.014","article-title":"Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation","volume":"4","author":"Ohgo","year":"2007","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0560","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12471-014-0523-2","article-title":"Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes","volume":"22","author":"Olde Nordkamp","year":"2014","journal-title":"Netherlands Heart Journal"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0565","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1054\/jelc.2001.26318","article-title":"Aborted sudden death, transient Brugada pattern, and wide QRS dysrhythmias after massive cocaine ingestion","volume":"34","author":"Ortega-Carnicer","year":"2001","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0570","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0306-3623(99)00048-8","article-title":"Cardiac electrophysiological effects of citalopram in guinea pig papillary muscle comparison with clomipramine","volume":"34","author":"Pacher","year":"2000","journal-title":"General Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0575","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s002109900154","article-title":"Electrophysiological effects of fluoxetine in mammalian cardiac tissues","volume":"361","author":"Pacher","year":"2000","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0580","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.hrthm.2012.02.023","article-title":"Genetic variants in SCN5A promoter are associated with arrhythmia phenotype severity in patients with heterozygous loss-of-function mutation","volume":"9","author":"Park","year":"2012","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0585","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1046\/j.1540-8167.2004.04388.x","article-title":"Fever as a precipitant of idiopathic ventricular fibrillation in patients with normal hearts","volume":"15","author":"Pasquie","year":"2004","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0590","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1046\/j.1540-8167.2001.01192.x","article-title":"Asymptomatic Brugada syndrome case unmasked during dimenhydrinate infusion","volume":"12","author":"Pastor","year":"2001","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0595","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00109-003-0522-z","article-title":"Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients","volume":"82","author":"Paulussen","year":"2004","journal-title":"Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0600","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1046\/j.1460-9592.2002.01646.x","article-title":"Fever unmasking the Brugada syndrome","volume":"25","author":"Porres","year":"2002","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0605","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/CIRCEP.108.790543","article-title":"Slow and discontinuous conduction conspire in Brugada syndrome: A right ventricular mapping and stimulation study","volume":"1","author":"Postema","year":"2008","journal-title":"Circulation. Arrhythmia and Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0610","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.hrthm.2009.07.002","article-title":"Drugs and Brugada syndrome patients: Review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)","volume":"6","author":"Postema","year":"2009","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0615","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.CIR.99.4.529","article-title":"Low penetrance in the long-QT syndrome: Clinical impact","volume":"99","author":"Priori","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0620","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: Document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0625","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/CIRCULATIONAHA.106.664219","article-title":"Clinical aspects and prognosis of Brugada syndrome in children","volume":"115","author":"Probst","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0630","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0014-5793(97)01249-0","article-title":"A mechanism for the proarrhythmic effects of cisapride (Propulsid): High affinity blockade of the human cardiac potassium channel HERG","volume":"417","author":"Rampe","year":"1997","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0635","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0026-895X(25)13362-2","article-title":"Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart","volume":"44","author":"Rampe","year":"1993","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0640","first-page":"H413","article-title":"Dispersion-based reentry: Mechanism of initiation of ventricular tachycardia in isolated rabbit hearts","volume":"276","author":"Robert","year":"1999","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0645","first-page":"656","article-title":"Rare cardiac arrhythmias of the pediatric age. II. Syncopal attacks due to paroxysmal ventricular fibrillation. (Presentation of 1st case in Italian pediatric literature)","volume":"45","author":"Romano","year":"1963","journal-title":"La Clinica Pediatrica"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0650","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.recesp.2012.01.013","article-title":"Brugada electrocardiogram pattern induced by cannabis","volume":"65","author":"Romero-Puche","year":"2012","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0655","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1540-8167.2001.00061.x","article-title":"Transient ST segment elevation in right precordial leads induced by psychotropic drugs: Relationship to the Brugada syndrome","volume":"12","author":"Rouleau","year":"2001","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0660","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/europace\/euv300","article-title":"Brugada syndrome: Clinical presentation and genotype-correlation with magnetic resonance imaging parameters","volume":"18","author":"Rudic","year":"2016","journal-title":"Europace: European Pacing, Arrythmias, and Cardiac Electrophysiology: Journal of the Worknig Groups on Cardiac Pacing, Arrythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0665","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jelectrocard.2013.10.008","article-title":"J wave elevation to monitor quinidine efficacy in early repolarization syndrome","volume":"47","author":"Sacher","year":"2014","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0670","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.76.1.110","article-title":"Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine","volume":"76","author":"Salata","year":"1995","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0675","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.hrthm.2009.05.016","article-title":"A novel SCN5A mutation V1340I in Brugada syndrome augmenting arrhythmias during febrile illness","volume":"6","author":"Samani","year":"2009","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0680","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0685","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/gim.2015.35","article-title":"Brugada syndrome: Clinical and genetic findings","volume":"18","author":"Sarquella-Brugada","year":"2016","journal-title":"Genetics in Medicine"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0690","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1046\/j.1460-9592.2002.t01-1-00856.x","article-title":"Brugada-like electrocardiographic pattern induced by fever","volume":"25","author":"Saura","year":"2002","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0695","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00210-003-0805-5","article-title":"Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired long QT syndrome by antiparkinsonian drug budipine","volume":"368","author":"Scholz","year":"2003","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0700","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","article-title":"Prevalence of the congenital long-QT syndrome","volume":"120","author":"Schwartz","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0705","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM199806113382401","article-title":"Prolongation of the QT interval and the sudden infant death syndrome","volume":"338","author":"Schwartz","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0710","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.CIR.30.1.17","article-title":"Quinidine syncope. Paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias","volume":"30","author":"Selzer","year":"1964","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0715","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1073\/pnas.180223197","article-title":"A common polymorphism associated with antibiotic-induced cardiac arrhythmia","volume":"97","author":"Sesti","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0720","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1046\/j.1540-8167.2000.01320.x","article-title":"Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome","volume":"11","author":"Shimizu","year":"2000","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0725","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.hrthm.2014.05.001","article-title":"Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes","volume":"11","author":"Shinohara","year":"2014","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0730","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nrcardio.2016.143","article-title":"Pathogenesis and management of Brugada syndrome","volume":"13","author":"Sieira","year":"2016","journal-title":"Nature Reviews Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0735","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s002280100298","article-title":"Study of the drug-drug interaction between simvastatin and cisapride in man","volume":"57","author":"Simard","year":"2001","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0740","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.joa.2015.11.009","article-title":"Molecular pathogenesis of long QT syndrome type 2","volume":"32","author":"Smith","year":"2016","journal-title":"Journal of Arrhythmia"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0745","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1126\/science.1073569","article-title":"Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia","volume":"297","author":"Splawski","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0750","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/europace\/eup332","article-title":"Brugada syndrome ECG provoked by the selective serotonin reuptake inhibitor fluvoxamine","volume":"12","author":"Stirnimann","year":"2010","journal-title":"Europace: European Pacing, Arrythmias, and Cardiac Electrophysiology: Journal of the Worknig Groups on Cardiac Pacing, Arrythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0755","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/WNF.0b013e3181e8ac66","article-title":"Brugada-like electrocardiographic pattern induced by lamotrigine toxicity","volume":"33","author":"Strimel","year":"2010","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0760","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.bjp.0700989","article-title":"The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes","volume":"120","author":"Suessbrich","year":"1997","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0765","article-title":"Type 1 Brugada pattern ECG due to supra-therapeutic phenytoin level","volume":"2016","author":"Swe","year":"2016","journal-title":"BML Case Reports"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0770","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2014.01.067","article-title":"Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome","volume":"63","author":"Szel","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0775","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.hrthm.2013.07.047","article-title":"Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome","volume":"10","author":"Szel","year":"2013","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0780","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1540-8159.2000.tb06773.x","article-title":"ST segment and T wave alternans in a patient with Brugada syndrome","volume":"23","author":"Tada","year":"2000","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0785","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1540-8167.2001.00275.x","article-title":"Brugada syndrome mimicked by tricyclic antidepressant overdose","volume":"12","author":"Tada","year":"2001","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0790","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1254\/jphs.SC0070243","article-title":"The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities","volume":"105","author":"Toga","year":"2007","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0795","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1540-8167.2002.00698.x","article-title":"Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome","volume":"13","author":"Tsuchiya","year":"2002","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0800","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.hrthm.2013.12.023","article-title":"Bilateral cardiac sympathetic denervation: The last resort?","volume":"11","author":"Turker","year":"2014","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161872","article-title":"A novel SCN5A mutation associated with drug induced Brugada type ECG","volume":"11","author":"Turker","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0810","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042037","article-title":"SCN5A mutations in Brugada syndrome are associated with increased cardiac dimensions and reduced contractility","volume":"7","author":"van Hoorn","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0815","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/hmg\/11.3.337","article-title":"Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome","volume":"11","author":"Vatta","year":"2002","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0820","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0041-008X(69)90066-0","article-title":"The toxicologic and pharmacologic properties of amantadine hydrochloride","volume":"15","author":"Vernier","year":"1969","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0825","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.hrthm.2005.11.005","article-title":"Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome","volume":"3","author":"Vernooy","year":"2006","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0830","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.hrthm.2006.05.030","article-title":"Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT\/VF. Anesthesia unmasked Brugada syndrome","volume":"3","author":"Vernooy","year":"2006","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0835","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/PL00005167","article-title":"Effect of disopyramide on potassium currents in rabbit ventricular myocytes","volume":"357","author":"Virag","year":"1998","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0840","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng0196-17","article-title":"Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias","volume":"12","author":"Wang","year":"1996","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0845","doi-asserted-by":"crossref","first-page":"H256","DOI":"10.1152\/ajpheart.00220.2002","article-title":"Functional and pharmacological properties of canine ERG potassium channels","volume":"284","author":"Wang","year":"2003","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0850","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/hmg\/4.9.1603","article-title":"Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia","volume":"4","author":"Wang","year":"1995","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0855","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(95)90359-3","article-title":"SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome","volume":"80","author":"Wang","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0860","first-page":"103","article-title":"A new familial cardiac syndrome in children","volume":"54","author":"Ward","year":"1964","journal-title":"Journal of the Irish Medical Association"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0865","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/eurheartj\/ehl060","article-title":"Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome","volume":"27","author":"Watanabe","year":"2006","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0870","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/jhg.2015.97","article-title":"Genetics of Brugada syndrome","volume":"61","author":"Watanabe","year":"2016","journal-title":"Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0875","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1053\/euhj.2002.3382","article-title":"Proposed diagnostic criteria for the Brugada syndrome","volume":"23","author":"Wilde","year":"2002","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0880","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.hrthm.2004.11.025","article-title":"Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome","volume":"2","author":"Wolpert","year":"2005","journal-title":"Heart Rhythm: The Official Journal of the Heart Rhythm Society"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0885","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.pa.36.040196.001313","article-title":"Cardiac actions of antihistamines","volume":"36","author":"Woosley","year":"1996","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0890","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/jama.1993.03500120070028","article-title":"Mechanism of the cardiotoxic actions of terfenadine","volume":"269","author":"Woosley","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0895","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/01.RES.69.3.644","article-title":"Evidence for developmental changes in sodium channel inactivation gating and sodium channel block by phenytoin in rat cardiac myocytes","volume":"69","author":"Xu","year":"1991","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0900","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.CIR.100.15.1660","article-title":"Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation","volume":"100","author":"Yan","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0905","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1056\/NEJM199810013391404","article-title":"Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group","volume":"339","author":"Zareba","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2017.05.001_bb0910","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/01.CIR.84.3.1414","article-title":"The long QT interval syndrome. A Rosetta stone for sympathetic related ventricular tachyarrhythmias","volume":"84","author":"Zipes","year":"1991","journal-title":"Circulation"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725817301201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725817301201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T17:49:30Z","timestamp":1750268970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725817301201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":183,"alternative-id":["S0163725817301201"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2017.05.001","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}